Cargando…
β(2)-agonists do not work in children under 2 years of age: myth or maxim?
Wheezy infants do not respond to bronchodilators despite evidence of functioning β-adrenoceptors. This is because the predominant aetiology, bronchiolitis, is characterised by small airway oedema and increased mucus, for which β(2)-agonists are ineffective. http://bit.ly/2Ws9ffh
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885336/ https://www.ncbi.nlm.nih.gov/pubmed/31803260 http://dx.doi.org/10.1183/20734735.0255-2019 |
| _version_ | 1783474722232598528 |
|---|---|
| author | Yusuf, Fatima Prayle, Andrew P. Yanney, Michael P. |
| author_facet | Yusuf, Fatima Prayle, Andrew P. Yanney, Michael P. |
| author_sort | Yusuf, Fatima |
| collection | PubMed |
| description | Wheezy infants do not respond to bronchodilators despite evidence of functioning β-adrenoceptors. This is because the predominant aetiology, bronchiolitis, is characterised by small airway oedema and increased mucus, for which β(2)-agonists are ineffective. http://bit.ly/2Ws9ffh |
| format | Online Article Text |
| id | pubmed-6885336 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68853362019-12-04 β(2)-agonists do not work in children under 2 years of age: myth or maxim? Yusuf, Fatima Prayle, Andrew P. Yanney, Michael P. Breathe (Sheff) Editorials Wheezy infants do not respond to bronchodilators despite evidence of functioning β-adrenoceptors. This is because the predominant aetiology, bronchiolitis, is characterised by small airway oedema and increased mucus, for which β(2)-agonists are ineffective. http://bit.ly/2Ws9ffh European Respiratory Society 2019-12 /pmc/articles/PMC6885336/ /pubmed/31803260 http://dx.doi.org/10.1183/20734735.0255-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Editorials Yusuf, Fatima Prayle, Andrew P. Yanney, Michael P. β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| title | β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| title_full | β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| title_fullStr | β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| title_full_unstemmed | β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| title_short | β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| title_sort | β(2)-agonists do not work in children under 2 years of age: myth or maxim? |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885336/ https://www.ncbi.nlm.nih.gov/pubmed/31803260 http://dx.doi.org/10.1183/20734735.0255-2019 |
| work_keys_str_mv | AT yusuffatima b2agonistsdonotworkinchildrenunder2yearsofagemythormaxim AT prayleandrewp b2agonistsdonotworkinchildrenunder2yearsofagemythormaxim AT yanneymichaelp b2agonistsdonotworkinchildrenunder2yearsofagemythormaxim |